0001209191-20-050353.txt : 20200914 0001209191-20-050353.hdr.sgml : 20200914 20200914204312 ACCESSION NUMBER: 0001209191-20-050353 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200910 FILED AS OF DATE: 20200914 DATE AS OF CHANGE: 20200914 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BEHRENS M KATHLEEN CENTRAL INDEX KEY: 0001211701 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39045 FILM NUMBER: 201174498 MAIL ADDRESS: STREET 1: 6701 KAISER DRIVE CITY: FREMONT STATE: CA ZIP: 94555 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IGM Biosciences, Inc. CENTRAL INDEX KEY: 0001496323 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770349194 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 325 E MIDDLEFIELD ROAD CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 650-965-7873 MAIL ADDRESS: STREET 1: 325 E MIDDLEFIELD ROAD CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 FORMER COMPANY: FORMER CONFORMED NAME: Palingen, Inc. DATE OF NAME CHANGE: 20100712 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-09-10 0 0001496323 IGM Biosciences, Inc. IGMS 0001211701 BEHRENS M KATHLEEN C/O IGM BIOSCIENCES, INC. 325 E. MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 1 0 0 0 Common Stock 2020-09-10 4 P 0 978 56.406 A 64192 D Common Stock 2020-09-10 4 P 0 2367 57.7488 A 66559 D Common Stock 2020-09-10 4 P 0 5132 58.7512 A 71691 D Common Stock 2020-09-10 4 P 0 4442 59.646 A 76133 D Common Stock 2020-09-10 4 P 0 5033 60.8648 A 81166 D Common Stock 2020-09-10 4 P 0 4336 61.8044 A 85502 D Common Stock 2020-09-10 4 P 0 2791 63.0611 A 88293 D Common Stock 2020-09-10 4 P 0 3351 63.5762 A 91644 D Common Stock 2020-09-10 4 P 0 1570 64.7955 A 93214 D Common Stock 10000 I See footnote Common Stock 10000 I See footnote The purchase price reported in column 4 of Table I represents the weighted average purchase price of the shares purchased ranging from $56.00 to $56.985 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price. The purchase price reported in column 4 of Table I represents the weighted average purchase price of the shares purchased ranging from $57.24 to $58.235 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price. The purchase price reported in column 4 of Table I represents the weighted average purchase price of the shares purchased ranging from $58.25 to $59.23 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price. The purchase price reported in column 4 of Table I represents the weighted average purchase price of the shares purchased ranging from $59.27 to $60.205 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price. The purchase price reported in column 4 of Table I represents the weighted average purchase price of the shares purchased ranging from $60.28 to $61.27 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price. The purchase price reported in column 4 of Table I represents the weighted average purchase price of the shares purchased ranging from $61.32 to $62.31 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price. The purchase price reported in column 4 of Table I represents the weighted average purchase price of the shares purchased ranging from $62.36 to $63.355 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price. The purchase price reported in column 4 of Table I represents the weighted average purchase price of the shares purchased ranging from $63.3625 to $64.10 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price. The purchase price reported in column 4 of Table I represents the weighted average purchase price of the shares purchased ranging from $64.475 to $65.245 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price. The shares are held in the name of Non-Exempt Trust for Patrick R. Wilsey Under the Alfred S. Wilsey, Jr. Revocable Trust for which Reporting Person is a Trustee. The shares are held in the name of Non-Exempt Trust for Shannon K. Wilsey Under the Alfred S. Wilsey, Jr. Revocable Trust for which Reporting Person is a Trustee. /s/ Misbah Tahir, by power of attorney 2020-09-14